NCT07165730Not yet recruiting
Virtual Health Coaching With Artificial Intelligence for Glycemic Control in Type 2 Diabetes
Effectiveness of Virtual Health Coaching Based on Artificial Intelligence to Improve Glycemic Control in Patients With Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 10 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of a virtual health coaching program based on artificial intelligence (AI) in improving blood sugar control among people with type 2 diabetes in primary health care settings in Jeneponto and Bantaeng, Indonesia. The intervention will be delivered through the DIACOACH application, which provides personalized coaching, lifestyle guidance, and self-care support. Participants will be randomly assigned to either the intervention group, receiving virtual health coaching for 12 weeks, or the control group, receiving standard diabetes education. Main outcomes include fasting blood sugar and HbA1c levels. Other outcomes include self-care adherence, dietary behavior, and quality of life. This trial seeks to provide evidence on whether AI-based virtual coaching is a practical and effective digital health solution to support diabetes self-management in community health settings with limited resources.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 206 (estimated)
- First submitted
- 3 Sept 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Hasanuddin University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07165730
What you commit to
- Study type: Interventional
- Planned participants: 206
- From 15 Sept 2025 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients on long-term steroid therapy
Other illness
- Diagnosed with Type 1 Diabetes Mellitus
- Patients with severe complications (e.g., advanced nephropathy, retinopathy, cardiovascular disease)
Other
- Patients currently undergoing other structured interventions
- Patients without access to a digital device
Who the study is looking for
- Diagnosed with Type 2 Diabetes Mellitus for more than 3 months
- Age between 30 and 56 years
- Able to read and understand instructions
- Have access to a digital device (smartphone or similar)
- In stable clinical condition
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Public Health Center of Bontomatene and Public Health Center of Binamu Kota Coordinator of this site? Confirm its status | Makassar | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.